Search Results - "Peinert, S"
-
1
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
Published in Gene therapy (01-05-2010)“…We have evaluated the carbohydrate antigen Lewis Y (Le Y ) as a potential target for T-cell immunotherapy of hematological neoplasias. Analysis of 81 primary…”
Get full text
Journal Article -
2
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype
Published in Gene therapy (01-09-2010)“…The anti-tumor efficacy of adoptively transferred T cells requires their in vivo persistence and memory polarization. It is unknown if human chimeric antigen…”
Get full text
Journal Article -
3
-
4
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice
Published in Gene therapy (01-07-2008)“…There is considerable concern regarding the transforming potential of retroviral vectors currently used for gene therapy, with evidence that retroviral…”
Get full text
Journal Article -
5
-
6
Genetic modification of haematopoietic cells for combined resistance to podophyllotoxins, other agents covered by MDR1-mediated efflux activity and nitrosoureas
Published in Bone marrow transplantation (Basingstoke) (01-05-2000)“…Genetic transfer and expression of drug-resistance functions into haematopoietic stem and progenitor cells is a promising means to overcome both the acute and…”
Get full text
Journal Article -
7
The Lewis-Y Carbohydrate Antigen is Expressed by Many Human Tumors and Can Serve as a Target for Genetically Redirected T cells Despite the Presence of Soluble Antigen in Serum
Published in Journal of immunotherapy (1997) (01-04-2009)“…In this study we aimed to determine the suitability of the Lewis-Y carbohydrate antigen as a target for immunotherapy using genetically redirected T cells…”
Get full text
Journal Article -
8
Ex vivo culture of chimeric antigen receptor T cells generates functional [CD8.sup.+] T cells with effector and central memory-like phenotype
Published in Gene therapy (01-09-2010)“…The anti-tumor efficacy of adoptively transferred T cells requires their in vivo persistence and memory polarization. It is unknown if human chimeric antigen…”
Get full text
Journal Article -
9
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8 super(+) T cells with effector and central memory-like phenotype
Published in Gene therapy (01-09-2010)“…The anti-tumor efficacy of adoptively transferred T cells requires their in vivo persistence and memory polarization. It is unknown if human chimeric antigen…”
Get full text
Journal Article -
10
BECAM: A salvage protocol with bevacizumab, capecitabin, and mitomycin C for patients with refractory metastatic colorectal cancer (CRC) or gastric cancer (GC)
Published in Journal of clinical oncology (20-06-2006)“…Abstract only 13554 Background: Bevacizumab (Bev), a monoclonal antibody targeted against VEGF, has shown to improve efficacy in CRC when combined with…”
Get full text
Journal Article -
11
High Response Rates with the Combination of Bortezomib, Dexamethasone and the Pan-Histone Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma in a Phase I/II Clinical Trial
Published in Blood (16-11-2008)“…INTRODUCTION: Proteasome inhibitors (PI) and histone deacetylase inhibitors (HDACi) have demonstrated synergistic pre-clinical activity in multiple myeloma…”
Get full text
Journal Article -
12
Cetuximab with oxaliplatin and capecitabine (CAPOX)in patients with metastatic colorectal cancer (mCRC) refractory to standard chemotherapy
Published in Journal of clinical oncology (01-06-2005)“…Abstract only…”
Get full text
Journal Article -
13
Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplatin (L-OHP) and irinotecan (CPT-11) [FUFOXIRI] for patients with metastatic gastric or colorectal cancer
Published in Journal of clinical oncology (01-06-2005)“…Abstract only…”
Get full text
Journal Article -
14
Genetic protection of repopulating hematopoietic cells with an improved MDR1‐retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice
Published in International journal of cancer (10-04-2002)“…This study was undertaken to analyze the hematotoxicity of paclitaxel (Taxol®) and to test whether transduction of repopulating hematopoietic cells with a…”
Get full text
Journal Article